STO:ODI

ODI Pharma AB · STO · Healthcare · SEK · FY for 2026

Figures on this page computed 2026-11-08 12:27 UTC

Last close

n/aSEK

Market data

14.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed

Safety is the furthest below its sector's middle: 0.46 against 0.63 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

What it sells, to whom

lens 8 of 9

The filer tagged nothing for this, so there is nothing filed to draw.

Nothing is drawn in its place. The other lenses are unaffected.

This filer tagged no segment and no customer.